TP53 and head and neck cancer: We found that roscovitine upregulates p53 in head and neck cancer cells regardless of p53 mutation and HPV status (Figure 1B; HPV-negative SCC61 cells harbor mutant p53, while HPV-positive UMSCC47 cells have wild type p53).